Overview

A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of Velcade when used with chemoradiation in cancer patients.
Phase:
Phase 1
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Thomas Jefferson University
Collaborator:
Millennium Pharmaceuticals, Inc.
Treatments:
Bortezomib